Skip to main content
. 2021 Sep 6;2021(9):CD011556. doi: 10.1002/14651858.CD011556.pub2

Twardella 2007.

Study characteristics
Methods Design: 4‐group cluster‐randomized controlled trial
Setting: Primary care in the Rhine–Neckar region, Germany
Recruitment: Providers recruited patients in practice
Participants 587 adults aged 36 – 75 years who smoked at least 10 cigarettes/day, av. age not reported, av. cpd not reported
Interventions Intervention 1:
• General medical practitioners received a 2‐hour cost‐free group tutorial in methods of promoting smoking cessation. The general medical practitioners were assured a financial remuneration of EUR 130 after study completion for each study participant they recruited who was abstinent at 12 months follow‐up
Intervention 2:
• General medical practitioners received a 2‐hour cost‐free group tutorial in methods of promoting smoking cessation
• Participants were reimbursed up to EUR 130 for the purchase of nicotine replacement therapy or bupropion for up to 12 months.
Intervention 3:
• General medical practitioners received a 2‐hour cost‐free group tutorial in methods of promoting smoking cessation. General practitioners were assured a financial remuneration of EUR 130 after study completion for each study participant they recruited who was abstinent at 12 months follow‐up
• Participants were reimbursed up to EUR 130 for the purchase of nicotine replacement therapy or bupropion for up to 12 months
Control: usual care. No further details reported
Outcomes 6m sustained at 12m
Validation: Salivary cotinine <15 ng/ml
Funding Source Funded by the German Ministry of Education andResearch (Bundesministerium für Bildung und Forschung), project number01EB0113, within the context of the Baden–Wurttemberg Research Network on Addiction (project 01EB0113)
Author's declarations of interest Authors declared that they had no competing interests.
Notes Strategy: Provider training + Provider incentive + Cost‐free medication
Level: Provider + Patient
Comparison type: Active vs. active (isolating cost‐free medications & provider incentive) & multicomponent vs. standard care
Risk of bias
Bias Authors' judgement Support for judgement
Sequence Generation Low risk Computer‐generated random sequence used
Allocation concealment Low risk QUOTE: "Randomisation was performed centrally at the German Center for Research on Ageing, Heidelberg, Germany...". Computer‐generated random sequence used
Blinding of outcome assessors
All outcomes Low risk Smoking status validated biochemically
Incomplete outcome data
All outcomes Low risk At participant level, the overall loss to follow‐up was 15.0% (n = 88/588); 19.7% (n = 15/76) in the usual care group, 15.1% (n = 22/146) in the TI group, 15.9% (n = 23/145) in the TM group, 12.7% (n = 28/221) in the TM+TI group were lost at 12‐month follow‐up
Recruitment bias (cluster RCTs only) Low risk Participants were affiliated with the practice before randomization
Balanced baseline characteristics? (cluster RCTs only) High risk In arms TM and TI+TM, the proportion of participants in the pre‐contemplation stage was lower, and the proportion of participants in both the contemplation and preparation stages were higher than in the usual care and TI arms (P < 0.001)
Adjustment for clustering in analysis? (cluster RCTs only) Low risk QUOTE: "The effect of both interventions on smoking abstinence at 12 months follow‐up was assessed simultaneously in a mixed logistic regression model accounting for cluster randomisation ‐ that is, including a random effect for medical practice in the model..."